Operational difficulties with internal pilot studies to update sample size

Drug Information Journal

Volumn 34, Issue 2, 2000, Pages 461-468

  Day, Simon ^a  

^a Leo Pharmaceuticals   (United Kingdom)

Author keywords

Clinical trial; Internal pilot study; Operational bias; Sample size; Sequential methods

Indexed keywords

CLINICAL RESEARCH; DECISION MAKING; MATHEMATICAL MODEL; PILOT STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SAMPLE; SAMPLING;

EID: 0034121905     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400215     Document Type: Review

References (23)

1. Wittes J, Brittain E. The role of internal pilot studies in increasing the efficiency of clinical trials. Stat Med. 1990;9:65-72.
2. Gould AL. Interim analyses for monitoring clinical trials that do not materially affect the Type I error rate. Stat Med. 1992;11:55-66.
3. Birkett MA, Day SJ. Internal pilot studies for estimating sample size. Stat Med. 1990;13:2455-2463.
4. Sandvik L, Erikssen J, Mowinckel P, Rødland EA. A method for determining the size of internal pilot studies. Stat Med. 1996;15:1587-1590.
5. Denne JS, Jennison C. Estimating the sample size for a f-test using an internal pilot. Stat Med. 1999; 18:1575-1585.
6. Wittes J, Schabenberger O, Zucker D, Brittain E, Proschan M. Internal pilot studies I: type I error rate of the naïve t-test. Stat Med. 1999;18:3481-3491.
7. Zucker DM, Wittes JT, Schabenberger O, Brittain E. Internal pilot studies II: comparison of various procedures. Stat Med. 1999;18:3493-3509.
8. Proschan MA, Hunsberger SA. Designed extension of studies based on conditional power. Biometrics. 1995;51:1315-1324.
9. Xamoterol in Severe Heart Failure Study Group. Xamoterol in severe heart failure. The Lancet. 1990; 336:1-6.
10. Lehr R. Sixteen S-squared over D-squared: a relation for crude sample size estimates. Stat Med. 1992;11: 1099-1102.
11. Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika. 1977;64: 191-199.
12. Pocock SJ. Interim analyses for randomized clinical trials: the group sequential approach. Biometrics. 1982;38:153-162.
13. Smith R, Roberts I. An amnesty for unpublished trials. Br Med J. 1997;315:622.
14. th meeting of the International Society for Clinical Biostatistics. Basle, 1994.
15. Day S. Optimal placebo response rates for comparing two binomial proportions. Stat Med. 1988;7: 1187-1194.
16. Wiles A, Atkinson G, Huson L, Morse P, Struthers L. Good statistical practice in clinical research: guideline standard operating procedures. Drug Inf J. 1994;28:615-628.
17. North PM. Ensuring good statistical practice in clinical research: guidelines for standard operating procedures (an update). Drug Inf J. 1998;32:665-682.
18. Ellenberg S, Geller N, Simon R, Yusuf S (Eds.) Proceeding of the meeting on practical issues in data monitoring of clinical trials. Stat Med. 1993; 12:415-616.
19. Peace KE, (Ed). Biopharmaceutical Sequential Statistical Applications. New York: Marcel Dekker; 1992.
20. Day S. Book review. Stat Med. 1993;12:2059.
21. Whitehead J. On being a statistician on a data and safety monitoring board. Stat Med. 1999;18:3425-3433.
22. Peace KE. Discussion for interim analysis and sample size reestimation. Drug Inf J. 1993;27:765-769.
23. Herson J, Wittes J. The use of interim analysis for sample size adjustment. Drug Inf J. 1993;27:753-760.